381 related articles for article (PubMed ID: 17437485)
1. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
[TBL] [Abstract][Full Text] [Related]
2. Plasma neuropeptides and perception of pruritus in psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Acta Derm Venereol; 2007; 87(4):299-304. PubMed ID: 17598031
[TBL] [Abstract][Full Text] [Related]
3. The role of selected neuropeptides in pathogenesis of atopic dermatitis.
Salomon J; Baran E
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):223-8. PubMed ID: 18211417
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis.
Maintz L; Wardelmann E; Walgenbach K; Fimmers R; Bieber T; Raap U; Novak N
Allergy; 2011 Jul; 66(7):862-9. PubMed ID: 21284654
[TBL] [Abstract][Full Text] [Related]
5. Plasma neuropeptide levels in psoriasis.
Mozzanica N; Cattaneo A; Vignati G; Finzi A
Acta Derm Venereol Suppl (Stockh); 1994; 186():67-8. PubMed ID: 7521105
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure.
Strauss GI; Edvinsson L; Larsen FS; Møller K; Knudsen GM
Neuropeptides; 2001; 35(3-4):174-80. PubMed ID: 11884208
[TBL] [Abstract][Full Text] [Related]
7. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
8. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.
Caviedes-Bucheli J; Lombana N; Azuero-Holguín MM; Munoz HR
Int Endod J; 2006 May; 39(5):394-400. PubMed ID: 16640639
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases.
El-Sayed ZA; Mostafa GA; Aly GS; El-Shahed GS; El-Aziz MM; El-Emam SM
Rheumatology (Oxford); 2009 Jul; 48(7):843-8. PubMed ID: 19465591
[TBL] [Abstract][Full Text] [Related]
10. Plasma neuropeptides in patients undergoing lumbar discectomy.
Takeuchi H; Kawaguchi S; Ohwada O; Kobayashi H; Hayakawa M; Takebayashi T; Torigoe T; Sato N; Yamashita T
Spine (Phila Pa 1976); 2007 Jan; 32(2):E79-84. PubMed ID: 17224803
[TBL] [Abstract][Full Text] [Related]
11. Plasma neuropeptides in hyperthyroidism.
Erfurth EM; Ekman R; Ahrén B
Thyroidology; 1990 Aug; 2(2):59-63. PubMed ID: 1724911
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
[TBL] [Abstract][Full Text] [Related]
13. Alterations in colonic arterial and venous plasma neuropeptide concentrations in horses during low-flow ischemia and reperfusion of the large colon.
Moore RM; Charalambous AC; Masty J
Am J Vet Res; 1996 Aug; 57(8):1200-5. PubMed ID: 8836375
[TBL] [Abstract][Full Text] [Related]
14. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
15. Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
Başak PY; Vural H; Kazanoglu OO; Erturan I; Buyukbayram HI
Int J Dermatol; 2014 Dec; 53(12):1526-30. PubMed ID: 25209952
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
[TBL] [Abstract][Full Text] [Related]
17. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
18. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
19. Correlation of gut hormones with irritable bowel syndrome.
Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma concentrations of vasoactive neuropeptides in patients with sepsis and septic shock.
Arnalich F; Sánchez JF; Martínez M; Jiménez M; López J; Vázquez JJ; Hernanz A
Life Sci; 1995; 56(2):75-81. PubMed ID: 7529863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
